Related Experiment Videos
Unproved methods and theories in allergy
Anne C Miranowski1, Paul A Greenberger
1Northwestern University, Department of Medicine, USA.
Allergy and Asthma Proceedings
|November 2, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
World Allergy Organization survey on the diagnosis and management trends of perioperative anaphylaxis.
The World Allergy Organization journal·2026
Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee.
The World Allergy Organization journal·2024
Global disparities in availability of epinephrine auto-injectors.
The World Allergy Organization journal·2023
Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
The Journal of allergy and clinical immunology·2022
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
Allergy and asthma proceedings·2021
Key factors in the diagnosis of sesame allergy in children.
Allergy and asthma proceedings·2026
Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.
Allergy and asthma proceedings·2026
Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.
Allergy and asthma proceedings·2026
The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.
Allergy and asthma proceedings·2026
The impact of dietary patterns on the risk of asthma in children.
Allergy and asthma proceedings·2026
The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.
Allergy and asthma proceedings·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026